References
- Abe N, Ito T, Ohguchi K, Nasu M, Masuda Y, Oyama M, Nozawa Y, et al. 2010. Resveratrol Oligomers from Vatica albiramis. J Nat Prod 73:1499–1506
- Ballinger A, Peikin SR. 2002. Orlistat: its current status as an anti-obesity drug. Eur J Pharmacol 440:109–117
- Birari RB, Bhutani KK. 2007. Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discov Today 12:879–889
- Cooke D, Bloom S. 2006. The obesity pipeline: current strategies in the development of anti-obesity drugs. Nat Rev Drug Discov 5:919–931
- Frankel EN, Waterhouse AL, Teissedre PL. 1995. Principal phenolic phytochemicals in selected California wines and their antioxidant activity in inhibiting oxidation of human low-density liporproteins. J Agric Food Chem 43:890–894
- Gosslau A, Pabbaraja S, Knapp S, Chen KY. 2008. Trans- and cis-stilbene polyphenols induced rapid perinuclear mitochondrial clustering and p53-independent apoptosis in cancer cells but not normal cells. Eur J Pharmacol 587:25–34
- Hadfield JA, Gaukroger K, Hirst N, Weston AP, Lawrence NJ, McGown AT. 2005. Synthesis and evaluation of double bond substituted combretastatins. Eur J Med Chem 40:529–541
- Huang KS, Lin M, Cheng GF. 2001. Anti-inflammatory tetramers of resveratrol from the roots of Vitis amurensis and the conformations of the seven-membered ring in some oligostilbenes. Phytochemistry 58:357–362
- Jiang L, He S, Sun C, Pan Y. 2012. Selective 1O2 quenchers, oligostilbenes, from Vitis wilsonae: structural identification and biogenetic relationship. Phytochemistry 77:294–303
- Khan MA, Nabi SG, Prakash S, Zaman A. 1986. Pallidol, a resveratrol dimer from Cissus pallidoa. Phytochemistry 25:1945–1948
- Kim JH, Kim HJ, Park HW, Youn SH, Choi DY, Shin CS. 2007. Development of inhibitors against lipase and alpha-glucosidase from derivatives of monascus pigment. FEMS Microbiol Lett 276:93–98
- Lee EO, Lee HJ, Hwang HS, Ahn KS, Chae C, Kang KS, Lu J, Kim SH. 2006. Potent inhibition of Lewis lung cancer growth by heyneanol A from the roots of Vitis amurensis through apoptotic and anti-angiogenic activities. Carcinogenisis 27:2056–2069
- Li WW, Ding LS, Li BG, Chen YZ. 1996. Oligostilbenes from Vitis heynana. Phytochemistry 42:1163–1165
- Lowe ME. 1994. Pancreatic triglyceride lipase and colipase: insights into dietary fat digestion. Gastroenterology 107:1524–1536
- Matsuda H, Asao Y, Nakamura S, Hamao M, Sugimoto S, Hongo M, Pongpiriyadacha Y, Yoshikawa M. 2009. Antidiabetogenic constituents from the Thai traditional medicine Cotylelobium melanoxylon. Chem Pharm Bull 57:487–494
- Monagas M, Hernandez-Ledesma B, Gomez-Cordoves C, Bartolome B. 2005. Commercial dietary ingredients from Vitis vinifera L. leaves and grape skins: antioxidant and chemical characterization. J Agric Food Chem 54:319–327
- Morikawa T, Chaipech S, Matsuda H, Hamao M, Umeda Y, Sato H, Tamaru H, et al. 2012. Anti-hyperlipidemic constituents from the bark of Shorea roxburghii. J Nat Med 66:516–524
- Peng SC, Cheng CY, Sheu F, Su CH. 2008. The antimicrobial activity of heyneanol A extracted from the root of Taiwanese wild grape. J Appl Microbiol 105:485–491
- Pettit GR, Rhodes MR, Herald DL, Hamel E, Schmidt JM, Pettit RK. 2005. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41. J Med Chem 48:4087–4099
- Romero-Pérez AI, Ibern-Gómez M, Lamuela-Raventós RM, de la Torre-Boronat MC. 1999. Piceid, the major resveratrol derivative in grape juices. J Agric Food Chem 47:1533–1536
- Yun JW. 2010. Possible anti-obesity therapeutics from nature – a review. Phytochemistry 71:1625–1641